Warning: The NCBI web site requires JavaScript to function. more...
The prevalence and significance of substance use disorders in bipolar type I and II disorder.
Cerullo MA, Strakowski SM.
Subst Abuse Treat Prev Policy. 2007 Oct 1;2:29.
Related citations
[Antipsychotics in bipolar disorders].
Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.
Beaulieu S, Saury S, Sareen J, Tremblay J, Schütz CG, McIntyre RS, Schaffer A.
Ann Clin Psychiatry. 2012 Feb;24(1):38-55.
ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.
Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. Epub 2008 May 23. Review.
Valproate for acute mood episodes in bipolar disorder.
Macritchie K, Geddes JR, Scott J, Haslam D, de Lima M, Goodwin G.
Cochrane Database Syst Rev. 2003;(1):CD004052. Review.
A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.
Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.
Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.
Arch Gen Psychiatry. 2005 Jan;62(1):37-45.
Treatments for late-life bipolar disorder.
Aziz R, Lorberg B, Tampi RR.
Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. Review.
Bipolar II disorder : epidemiology, diagnosis and management.
Benazzi F.
CNS Drugs. 2007;21(9):727-40. Review.
Pharmacotherapy of dual substance abuse and dependence.
Kenna GA, Nielsen DM, Mello P, Schiesl A, Swift RM.
CNS Drugs. 2007;21(3):213-37. Review.
A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R.
Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. Review.
Clinical correlates of patients with rapid-cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo-controlled trials.
Gao K, Verduin ML, Kemp DE, Tolliver BK, Ganocy SJ, Elhaj O, Bilali S, Brady KT, Findling RL, Calabrese JR.
J Clin Psychiatry. 2008 Jul;69(7):1057-63.
Tiagabine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability.
Young AH, Geddes JR, Macritchie K, Rao SN, Watson S, Vasudev A.
Cochrane Database Syst Rev. 2006 Jul 19;3:CD004694. Review.
Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Macritchie KA, Geddes JR, Scott J, Haslam DR, Goodwin GM.
Cochrane Database Syst Rev. 2001;(3):CD003196. Review.
Lithium for maintenance treatment of mood disorders.
Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G.
Cochrane Database Syst Rev. 2001;(3):CD003013. Review.
Cochrane Database Syst Rev. 2001;(2):CD003013. Review. Update in: Cochrane Database Syst Rev. 2001;(3):CD003013.
A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
Kollins SH.
Curr Med Res Opin. 2008 May;24(5):1345-57. Epub 2008 Apr 1. Review.
Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disorders.
Gao K, Chan PK, Verduin ML, Kemp DE, Tolliver BK, Ganocy SJ, Bilali S, Brady KT, Findling RL, Calabrese JR.
Am J Addict. 2010 Sep-Oct;19(5):440-9.
Epidemiology and management of anxiety in patients with bipolar disorder.
Kauer-Sant'Anna M, Kapczinski F, Vieta E.
CNS Drugs. 2009 Nov;23(11):953-64. doi: 10.2165/11310850-000000000-00000. Review.
Topiramate for acute affective episodes in bipolar disorder.
Vasudev K, Macritchie K, Geddes J, Watson S, Young A.
Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003384. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on